How is bronchospasm diagnosed?

How to Diagnose Bronchospasm

Bronchospasm is diagnosed through a combination of clinical history (episodic symptoms of airflow obstruction), physical examination findings (wheezing, prolonged expiration), and objective spirometry demonstrating reversible airflow obstruction—specifically an increase in FEV1 of ≥12% and ≥200 mL after inhaled short-acting β2-agonist administration. 1

Clinical Assessment

Key Symptom Indicators

Look for these specific features in the history:

• Episodic symptoms: Cough (particularly worse at night), recurrent wheeze, recurrent difficulty breathing, or recurrent chest tightness 1
• Trigger identification: Symptoms occur or worsen with exercise, viral infections, allergen exposure (pets, dust mites, mold, pollen), irritants (smoke, chemicals), weather changes, strong emotions, stress, or menstrual cycles 1
• Nocturnal awakening: Symptoms that occur or worsen at night 1

Physical Examination Findings

Focus on detecting:

• Upper respiratory tract: Increased nasal secretion, mucosal swelling, nasal polyps 1
• Chest findings: Wheezing during normal breathing or prolonged forced exhalation, hyperexpansion, accessory muscle use, hunched shoulders, chest deformity 1
• Skin: Atopic dermatitis or eczema 1

Important caveat: Physical examination may be completely normal between episodes due to the variable nature of bronchospasm, so normal findings do not rule out the diagnosis 1.

Objective Diagnostic Testing

Spirometry with Bronchodilator Testing (Primary Diagnostic Tool)

Spirometry is essential and superior to peak flow meters for diagnosis 1. The diagnostic algorithm proceeds as follows:

1. Baseline spirometry: Perform in patients ≥5 years old to demonstrate airflow obstruction (FEV1/FVC <0.7) 1, 2

2. Bronchodilator responsiveness testing: Administer a short-acting β2-agonist and repeat spirometry

   • Positive test: FEV1 increase of ≥12% AND ≥200 mL from baseline confirms reversible airflow obstruction 1
   • Some evidence suggests ≥10% of predicted FEV1 improvement may better differentiate asthma from COPD 1

3. Post-bronchodilator interpretation: Use post-bronchodilator FEV1/FVC <0.7 to confirm persistent obstruction in COPD 3, 2, while significant reversibility suggests asthma 1

When Spirometry is Normal or Near-Normal

If bronchospasm is suspected but spirometry is normal, proceed with bronchoprovocation testing 1:

Methacholine or histamine challenge:

• Perform only by trained personnel for safety 1
• Positive test demonstrates airway hyperresponsiveness characteristic of asthma 1
• Note: Positive test is consistent with but not specific for asthma; negative test is more helpful to rule out asthma 1

Exercise challenge test (for exercise-induced bronchospasm):

• Perform high-intensity exercise to achieve target ventilation 4, 5
• Measure FEV1 and/or peak expiratory flow (PEF) at baseline, then at 1,3,5,7,10,15, and 20 minutes post-exercise 6
• Diagnostic criteria: ≥10% decrease in FEV1 or ≥15% decrease in FEV1 and/or PEF post-exercise 4, 6, 7
• Critical timing: Bronchospasm may not appear until several minutes into recovery, requiring extended monitoring 4, 6

Mannitol challenge: Shows 80% sensitivity for detecting bronchial hyperresponsiveness in children with suspected exercise-induced bronchospasm 7

Diagnostic Algorithm for Exercise-Induced Bronchospasm

For suspected exercise-induced bronchospasm specifically 7, 8:

1. First-line approach: Trial of inhaled β2-agonist 15 minutes before exercise 8
2. If symptoms persist: Perform exercise challenge test with pre- and post-exercise spirometry 8
3. Optimal testing sequence (if multiple tests needed): Methacholine test first, followed by mannitol test—this combination detects bronchial hyperresponsiveness in 100% of children with suspected exercise-induced bronchospasm 7

Special Considerations

In Asthmatic Patients

• Premedicate with bronchodilator before bronchoscopy to prevent procedure-induced bronchospasm 9
• Bronchospasm during bronchoscopy occurs in 8% of asthmatic patients 9
• Lignocaine may paradoxically cause bronchoconstriction in asthmatics 9

Differential Diagnosis Requiring Exclusion

Before confirming bronchospasm as the primary diagnosis, consider 1:

• Vocal cord dysfunction (evaluate inspiratory flow-volume loops)
• Foreign body aspiration
• COPD (assess with diffusing capacity)
• Congestive heart failure
• Pulmonary embolism
• Gastroesophageal reflux disease

Adjunctive Testing (Not Routine)

• Chest X-ray: May be needed to exclude alternative diagnoses 1
• Fractional exhaled nitric oxide (FENO): Conditionally recommended as adjunct when diagnosis remains uncertain after history, examination, and spirometry 10

The cornerstone remains spirometry with bronchodilator testing—history and physical examination alone are unreliable for excluding other diagnoses or accurately assessing lung status 1.